Gainers
- 1847 Goedeker Inc. GOED shares jumped 156.5% to $11.08 after dropping over 8% on Wednesday.
- Vertex Energy, Inc. VTNR jumped 117% to $3.8604 after the company announced plans to acquire a Alabama refinery and related logistics assets.
- Rezolute, Inc. RZLT surged 56.1% to $12.00 after Oppenheimer initiated coverage on the stock with an Outperform rating and a $25 price target.
- Fangdd Network Group Ltd. DUO shares gained 27.4% to $4.04.
- Tellurian Inc. TELL surged 23.7% to $3.92 after the company, and Gunvor, announced they signed a 10-year LNG agreement for 3 mtpa.
- LAIX Inc. LAIX shares rose 22.2% to $1.92 after the company reported Q1 earnings.
- Moxian, Inc. MOXC rose 17.4% to $19.31 after dropping over 8% on Wednesday.
- Ooma, Inc. OOMA jumped 16.8% to $19.10 after the reported better-than-expected Q1 results and issued guidance above analyst estimates.
- Lantheus Holdings, Inc. LNTH surged 16.7% to $22.76 after the FDA approved the company’s Pylarify, a positron emission tomography (PET) imaging agent, to identify suspected metastasis or recurrence of prostate cancer.
- Pieris Pharmaceuticals, Inc. PIRS rose 16.7% to $3.9601. Pieris Pharmaceuticals recently announced a respiratory and ophthalmology collaboration with Genentech.
- Zosano Pharma Corporation ZSAN gained 15% to $0.8549 after the company announced publication of clinical data regarding the long-term use of Qtrypta for the treatment of acute migraine in The Journal of Headache and Pain.
- Titan Machinery Inc. TITN rose 14.9% to $29.38 following better-than-expected Q1 results.
- AMC Entertainment Holdings, Inc. AMC surged 14.5% to $22.42 amid renewed retail investor interest in the stock.
- Target Hospitality Corp. TH gained 14.2% to $3.70. Stifel upgraded Target Hospitality from Hold to Buy and raised the price target from $3 to $4.5.
- Syros Pharmaceuticals, Inc. SYRS jumped 14.1% to $6.38. The company published trial titled 'A Trial to Learn More About a Possible Treatment For Participants With Acute Myeloid Leukemia' to ClinicalTrials.Gov.
- BIT Mining Limited BTCM gained 12.6% to $7.97 after dropping 12% on Wednesday.
- Aqua Metals, Inc. AQMS surged 12.5% to $2.88.
- Intrusion Inc INTZ gained 12.1% to $14.21.
- Organogenesis Holdings Inc ORGO rose 11.9% to $18.60. Organogenesis will replace Crocs in the S&P SmallCap 600 on Wednesday, June 2.
- Vista Outdoor Inc. VSTO gained 10.8% to $44.29 following yesterday's investor day event. Analysts at Arus and Keybanc raised their price target on the stock.
- Beyond Meat, Inc. BYND jumped 9.8% to $139.15 after the company announced the launch of its first-ever value six-pack of its Beyond Burger in Canada.
- Property Solutions Acquisition Corp. PSAC rose 8.8% to $13.05.
- Creative Realities, Inc. CREX gained 8.3% to $1.9606. Creative Realities recently reported Q1 results.
- Eloxx Pharmaceuticals, Inc. ELOX shares rose 6.7% to $1.5048.
- Ault Global Holdings, Inc. DPW shares rose 6.3% to $2.8048. Ault Global recently reported Q1 results.
- Timber Pharmaceuticals, Inc. TMBR rose 6.2% to $1.2850 after the company announced completion of patient enrollment in Phase 2b CONTROL study evaluating TMB-001 in congenital ichthyosis.
Check out these big penny stock gainers and losers
Losers
- OneConnect Financial Technology Co., Ltd. OCFT fell 18.4% to $15.24.
- EZGO Technologies Ltd. EZGO shares dipped 16.2% to $4.7099 after the company reported pricing of upsized $12 million registered direct offering of 2.564 million shares.
- NextGen Healthcare, Inc. NXGN fell 14.2% to $16.07. NextGen Healthcare posted upbeat Q4 results, but issued weak earnings forecast for FY22.
- Anaplan, Inc. PLAN fell 11.5% to $50.44 after the company reported worse-than-expected Q1 earnings. The company also announced CFO David H. Morton, Jr will depart the company later this year.
- Okta, Inc. OKTA dropped 10.5% to $220.63 after the company issued Q2 adjusted EPS guidance below estimates.
- Protagenic Therapeutics, Inc. PTIX declined 10% to $2.42.
- Realogy Holdings Corp. RLGY dropped 9.7% to $17.54.
- Kintara Therapeutics, Inc. KTRA shares fell 8.4% to $1.6491 after jumping around 22% on Wednesday. The company recently announced that the VAL-083 treatment arm in the Global Coalition for Adaptive Research registrational Phase 2/3 trial for glioblastoma multiforme (GBM) has been activated.
- MINISO Group Holding Limited MNSO dropped 8.1% to $21.58. The company recently reported Q3 results.
- Dollar Tree, Inc. DLTR dipped 8% to $99.80 after the company reported Q1 earnings results. Dollar Tree said it sees FY21 earnings of $5.80 to $6.05 per share.
- Lizhi Inc. LIZI shares fell 7.9% to $6.30 after jumping 58% on Wednesday. Lizhi is expected to report Q1 results on June 1.
- Designer Brands Inc. DBI declined 7.1% to $18.06 after reporting weak quarterly sales.
- Nabriva Therapeutics plc NBRV fell 6.6% to $1.4105. Sinovant Sciences and Nabriva Therapeutics recently disclosed topline results from Phase 3 trial of lefamulin in Chinese adults with community acquired bacterial pneumonia.
- Genesco Inc. GCO fell 5.6% to $55.08 after reporting quarterly results.
- Invesco Mortgage Capital Inc. IVR dropped 5.1% to $3.40 as the company priced 37.5 million share common stock offering for gross proceeds of $128.625 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in